The amazing and inspiring Vincent DeVita, MD, professor of medicine at Yale Cancer Center and former president of ACS, former Physician-in-Chief of MSKCC, and someone who has held way too many national titles to count, debated with me some of the ideas laid out in his book, “The Death of Cancer,” most notably the utility of randomized controlled trials in regulatory approvals.
As a lymphoma specialist, this episode was a highlight of my podcasting career; speaking with a legend that I have always admired from afar. What a treat. Listen and let me know what you think.
This podcast is produced by the Journal of Clinical Pathways.
Dr. Pedro Barata, Director of the Clinical Genitourinary Medical Oncology Research Program at UH Seidman Cancer Center, provides an exclusive round-up of the most groundbreaking and practice-changing research unveiled at the ASCO GU 2024 meeting. With expertise and insight, he delves into pivotal studies such as CheckMate 914 Part B and KEYNOTE-564, exploring their implications
Dr. LaBelle elucidates the complexities of sickle cell disease, unraveling the devastating impact it has on individuals. The episode delves into various treatments and approaches to combat this formidable disease, including bone marrow transplant and the groundbreaking use of CRISPR-Cas9 technology. LaBelle shares insights into the recent research breakthroughs, citing the remarkable research report published
n this poignant episode, USA Today investigative journalist Emily Le Coz unravels the heart-wrenching narrative of Ashleigh Anderson, a CVS pharmacist whose tragic demise serves as a cautionary tale of overwhelming stress in the workplace. Emily shares her motivations behind delving into the pervasive issue of burnout in retail pharmacy and sheds light on the
